GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above | Antibodies | News Channels - PipelineReview.com

GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above | Antibodies | News Channels  PipelineReview.com

GSK receives US approval of Benlysta for intravenous use in children with lupus aged five years and above.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases